KR102148387B1 - 유전자 변형된 ｔ 세포 수용체 마우스 - Google Patents

유전자 변형된 ｔ 세포 수용체 마우스 Download PDF

Info

Publication number
KR102148387B1
KR102148387B1 KR1020197008815A KR20197008815A KR102148387B1 KR 102148387 B1 KR102148387 B1 KR 102148387B1 KR 1020197008815 A KR1020197008815 A KR 1020197008815A KR 20197008815 A KR20197008815 A KR 20197008815A KR 102148387 B1 KR102148387 B1 KR 102148387B1
Authority
KR
South Korea
Prior art keywords
human
cell
rodent
tcr
tcrβ
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197008815A
Other languages
English (en)
Korean (ko)
Other versions
KR20190037354A (ko
Inventor
린 맥도날드
앤드류 제이. 머피
존 맥훠터
나신 투
베라 보로니나
카간 규레르
캐롤리나 미거
션 스티븐스
Original Assignee
리제너론 파아마슈티컬스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리제너론 파아마슈티컬스, 인크. filed Critical 리제너론 파아마슈티컬스, 인크.
Priority to KR1020207024033A priority Critical patent/KR102321909B1/ko
Publication of KR20190037354A publication Critical patent/KR20190037354A/ko
Application granted granted Critical
Publication of KR102148387B1 publication Critical patent/KR102148387B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0387—Animal model for diseases of the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020197008815A 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스 Active KR102148387B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020207024033A KR102321909B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161552582P 2011-10-28 2011-10-28
US61/552,582 2011-10-28
US201261621198P 2012-04-06 2012-04-06
US61/621,198 2012-04-06
US201261700908P 2012-09-14 2012-09-14
US61/700,908 2012-09-14
PCT/US2012/062065 WO2013063361A1 (en) 2011-10-28 2012-10-26 Genetically modified t cell receptor mice

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020147014477A Division KR101964776B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020207024033A Division KR102321909B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스

Publications (2)

Publication Number Publication Date
KR20190037354A KR20190037354A (ko) 2019-04-05
KR102148387B1 true KR102148387B1 (ko) 2020-08-26

Family

ID=47178340

Family Applications (5)

Application Number Title Priority Date Filing Date
KR1020197008815A Active KR102148387B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스
KR1020147014477A Active KR101964776B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스
KR1020207024033A Active KR102321909B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스
KR1020227015694A Active KR102542272B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스
KR1020217035333A Active KR102397961B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스

Family Applications After (4)

Application Number Title Priority Date Filing Date
KR1020147014477A Active KR101964776B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스
KR1020207024033A Active KR102321909B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스
KR1020227015694A Active KR102542272B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스
KR1020217035333A Active KR102397961B1 (ko) 2011-10-28 2012-10-26 유전자 변형된 ｔ 세포 수용체 마우스

Country Status (25)

Country Link
US (4) US9113616B2 (enExample)
EP (3) EP3424947B1 (enExample)
JP (7) JP6254528B2 (enExample)
KR (5) KR102148387B1 (enExample)
CN (5) CN104011071B (enExample)
AU (5) AU2012327204B2 (enExample)
BR (1) BR112014009203B1 (enExample)
CA (1) CA2853707A1 (enExample)
CY (2) CY1120945T1 (enExample)
DK (2) DK2771357T3 (enExample)
ES (2) ES2691475T3 (enExample)
HR (2) HRP20181626T1 (enExample)
HU (1) HUE053444T2 (enExample)
IL (4) IL315445A (enExample)
IN (1) IN2014CN03890A (enExample)
LT (2) LT2771357T (enExample)
MX (2) MX379517B (enExample)
PL (2) PL2771357T3 (enExample)
PT (2) PT2771357T (enExample)
RS (2) RS61455B1 (enExample)
RU (1) RU2661106C2 (enExample)
SG (2) SG10201914043XA (enExample)
SI (2) SI2771357T1 (enExample)
SM (2) SMT202100243T1 (enExample)
WO (1) WO2013063361A1 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104011071B (zh) * 2011-10-28 2017-11-07 瑞泽恩制药公司 T细胞受体基因修饰小鼠
CN103212064B (zh) * 2012-01-19 2016-02-17 中国科学院上海巴斯德研究所 磷酸化途径相关因子在调控调节性t细胞功能中的应用
JP6275120B2 (ja) 2012-04-25 2018-02-07 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 大きい標的化ベクターによるヌクレアーゼ媒介標的化
GB2508414A (en) * 2012-11-30 2014-06-04 Max Delbrueck Centrum Tumour specific T cell receptors (TCRs)
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
EP3456831B1 (en) 2013-04-16 2021-07-14 Regeneron Pharmaceuticals, Inc. Targeted modification of rat genome
MX388127B (es) 2013-12-11 2025-03-19 Regeneron Pharma Metodos y composiciones para la modificacion dirigida de un genoma.
TWI681969B (zh) * 2014-01-23 2020-01-11 美商再生元醫藥公司 針對ｐｄ-１的人類抗體
BR112016028564A2 (pt) * 2014-06-06 2018-01-30 Regeneron Pharma método para modificar um locus-alvo em uma célula.
DK3157956T3 (da) 2014-06-19 2020-04-27 Regeneron Pharma Ikke-humane dyr med et humaniseret gen med programmeret celledød 1
SG10201911411YA (en) 2014-06-26 2020-02-27 Regeneron Pharma Methods and compositions for targeted genetic modifications and methods of use
KR20170083534A (ko) * 2014-09-19 2017-07-18 리제너론 파마슈티칼스 인코포레이티드 키메라 항원 수용체
CA3176380A1 (en) 2014-11-21 2016-05-26 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modification using paired guide rnas
BR112017010793A2 (pt) * 2014-11-24 2017-12-26 Regeneron Pharma animal não humano geneticamente modificado, camundongo, métodos para produzir um animal não humano geneticamente modificado e de triagem de candidatos a fármaco direcionados a um antígeno de interesse, e, modelo de camundongo.
BR112017013104A2 (pt) 2014-12-19 2018-05-15 Regeneron Pharma métodos para modificar um locus genômico alvo em uma célula, para intensificar a recombinação homóloga em um locus genômico alvo em uma célula e para produzir uma geração f0 de um animal não humano.
AU2016246698B2 (en) * 2015-04-06 2022-06-02 Regeneron Pharmaceuticals, Inc. Humanized T cell mediated immune responses in non-human animals
DE112016002056T5 (de) 2015-05-06 2018-02-08 Snipr Technologies Limited Verändern mikrobieller Populationen und Modifizieren von Mikrobiomen
PT3376857T (pt) 2015-11-20 2021-05-27 Regeneron Pharma Animais não humanos com um gene humanizado 3 de ativação de linfócitos
CA3020330A1 (en) * 2016-04-07 2017-10-12 Bluebird Bio, Inc. Chimeric antigen receptor t cell compositions
DK3440105T3 (da) 2016-04-08 2022-06-13 Immunocore Ltd T-cellereceptorer
IL263160B2 (en) * 2016-06-03 2024-01-01 Regeneron Pharma Non-human animals expressing exogenous terminal deoxynucleotidyltransferase
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
WO2018232318A1 (en) * 2017-06-16 2018-12-20 Mayo Foundation For Medical Education And Research Materials and methods for increasing immune responses
WO2019070541A1 (en) 2017-10-03 2019-04-11 Juno Therapeutics, Inc. HPV-SPECIFIC BINDING MOLECULES
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
MA52656A (fr) * 2018-04-05 2021-02-17 Editas Medicine Inc Procédés de production de cellules exprimant un récepteur recombinant et compositions associées
JP7422365B2 (ja) * 2018-07-26 2024-01-26 国立大学法人京都大学 外来抗原レセプター遺伝子導入細胞の製造方法
US11851663B2 (en) 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
WO2021050948A1 (en) * 2019-09-12 2021-03-18 TCR2 Therapeutics Inc. Compositions and methods for tcr reprogramming using fusion proteins
WO2021113297A1 (en) 2019-12-02 2021-06-10 Regeneron Pharmaceuticals, Inc. Peptide-mhc ii protein constructs and uses thereof
IL296827A (en) * 2020-03-27 2022-11-01 2Seventy Bio Inc t cell receptors
CN113684258B (zh) * 2020-05-18 2024-08-20 上海赛比曼生物科技有限公司 用于检测鼠源tcr转基因拷贝数的试剂盒及方法
IL307238A (en) 2021-03-31 2023-11-01 Regeneron Pharma Transgenic mice containing human components of the cellular immune system with an enhanced diversity of the TCRB repertoire
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
US20240114883A1 (en) * 2022-08-12 2024-04-11 Ingenious Targeting Laboratories Genetically modified non-human having humanized gamma and delta TCR variable genes
CN120476137A (zh) 2022-08-18 2025-08-12 英美偌科有限公司 对mage a4具有特异性的t细胞受体融合蛋白
EP4590120A1 (en) * 2022-09-22 2025-07-30 Regeneron Pharmaceuticals, Inc. Genetically modified mice expressing components of human cellular immune system
TW202520975A (zh) 2023-08-09 2025-06-01 英商劍橋企業有限公司 基因改造之囓齒動物及囓齒動物細胞以及其等用途
GB202405657D0 (en) 2024-04-22 2024-06-05 T Therapeutics Ltd T cell receptor identification and provision
GB2640828A (en) 2024-04-22 2025-11-12 T Therapeutics Ltd Methods and products for the generation and identification of T cells and TCRs

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006639A1 (fr) 2001-07-13 2003-01-23 Genoway Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
WO2005004592A2 (en) 2003-07-30 2005-01-20 Institut Pasteur Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
JP2005505236A (ja) 2000-12-19 2005-02-24 アルトー バイオサイエンス コーポレイション ヒト化免疫系を含むトランスジェニック動物
US20050050580A1 (en) 2000-12-13 2005-03-03 Masashi Gotoh Transgenic animal expressing hla-a24 and utilization thereof
WO2008010100A2 (en) 2006-07-13 2008-01-24 Institut Pasteur Immunodeficient mice transgenic for hla class i and hla class ii molecules and their uses
WO2011004192A1 (en) 2009-07-08 2011-01-13 Genome Research Limited Animal models and therapeutic molecules

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP0663952A4 (en) 1992-09-11 1997-06-11 Univ California Transgenic non-human animals having targeted lymphocyte transduction genes.
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
WO1997032603A1 (en) 1996-03-05 1997-09-12 The Scripps Research Institute Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
US6320306B1 (en) * 1996-08-05 2001-11-20 Samsung Display Devices Co., Ltd. Shadow mask with porous insulating layer and heavy metal layer
DE69738539T2 (de) 1996-12-03 2009-03-26 Amgen Fremont Inc. Vollkommen humane Antikörper die EGFR binden
WO2001027291A1 (en) 1999-10-12 2001-04-19 Institut Pasteur Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice
US7462486B2 (en) 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
JP4317940B2 (ja) 2001-08-31 2009-08-19 イミュノコア・リミテッド 物質
JP4087338B2 (ja) 2001-11-15 2008-05-21 キリンファーマ株式会社 キメラ非ヒト動物
ES2231382T3 (es) * 2001-12-22 2005-05-16 4-Antibody Ag Metodo para la generacion de linfocitos precursores de vertebrados geneticamente modificados, y uso de los mismos para la produccion de proteinas de union heterologas.
AU2002226390B2 (en) 2001-12-22 2007-11-15 4-Antibody Ag Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
DE10244457A1 (de) 2002-09-24 2004-04-01 Johannes-Gutenberg-Universität Mainz Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren
US7569664B2 (en) 2002-10-09 2009-08-04 Immunocore Limited Single chain recombinant T cell receptors
US20060156419A1 (en) 2002-10-30 2006-07-13 The Wistar Institute Of Anatomy And Biology Mouse model for autoimmune disorders
EP1802193B1 (en) 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
WO2007131092A2 (en) * 2006-05-03 2007-11-15 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Chimeric t cell receptors and related materials and methods of use
US9388425B2 (en) 2006-10-20 2016-07-12 Trustees Of Boston University Tunable genetic switch for regulating gene expression
JP2008159109A (ja) 2006-12-21 2008-07-10 Matsushita Electric Ind Co Ltd データ転送装置
TWI476280B (zh) 2008-03-07 2015-03-11 Regeneron Pharma 來自二倍體宿主胚胎注射之ｅｓ－細胞衍生的老鼠
US20090328240A1 (en) 2008-06-24 2009-12-31 Sing George L Genetically modified mice as predictors of immune response
WO2010107400A1 (en) * 2009-03-20 2010-09-23 Agency For Science, Technology And Research Genetically modified animal and method of obtaining the same
GB0917090D0 (en) 2009-09-29 2009-11-11 Ucl Biomedica Plc T-cell receptor
US10464987B2 (en) 2009-10-06 2019-11-05 Abbvie Inc. Human single-chain T cell receptors
US8956828B2 (en) 2009-11-10 2015-02-17 Sangamo Biosciences, Inc. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
WO2012039779A1 (en) 2010-09-24 2012-03-29 The United States Of America As Represented By The Secretary Of The Navy Humanized transgenic mouse model
CN105950654B (zh) 2010-11-27 2020-03-20 朱坚 一种人源化的转基因动物
CN104011071B (zh) * 2011-10-28 2017-11-07 瑞泽恩制药公司 T细胞受体基因修饰小鼠
AU2016246698B2 (en) 2015-04-06 2022-06-02 Regeneron Pharmaceuticals, Inc. Humanized T cell mediated immune responses in non-human animals

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050050580A1 (en) 2000-12-13 2005-03-03 Masashi Gotoh Transgenic animal expressing hla-a24 and utilization thereof
JP2005505236A (ja) 2000-12-19 2005-02-24 アルトー バイオサイエンス コーポレイション ヒト化免疫系を含むトランスジェニック動物
WO2003006639A1 (fr) 2001-07-13 2003-01-23 Genoway Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
WO2005004592A2 (en) 2003-07-30 2005-01-20 Institut Pasteur Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
WO2008010100A2 (en) 2006-07-13 2008-01-24 Institut Pasteur Immunodeficient mice transgenic for hla class i and hla class ii molecules and their uses
WO2011004192A1 (en) 2009-07-08 2011-01-13 Genome Research Limited Animal models and therapeutic molecules

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Eur. J. Immunol., vol.19(12), pp.2349-2354(1989).
J. Exp. Med., vol.170(4), pp.1091-1101(1989).
J. Exp. Med., vol.173(4), pp.1007-1015(1991).
J. Immunol., vol.149(1), pp.136-142(1992).
Nature, vol. 348(6302), pp.642-644(1990.12.13).

Also Published As

Publication number Publication date
AU2024204645A1 (en) 2024-08-01
IL305550A (en) 2023-10-01
AU2016202512B2 (en) 2018-03-29
KR20190037354A (ko) 2019-04-05
US9113616B2 (en) 2015-08-25
JP2018007696A (ja) 2018-01-18
AU2021203192A1 (en) 2021-06-10
SMT202100243T1 (it) 2021-05-07
BR112014009203A2 (pt) 2020-10-27
IL274914A (en) 2020-07-30
ES2858978T3 (es) 2021-09-30
KR20220066197A (ko) 2022-05-23
CN104011071B (zh) 2017-11-07
JP6532924B2 (ja) 2019-06-19
AU2012327204A1 (en) 2013-05-23
CN114891797A (zh) 2022-08-12
EP3795587A1 (en) 2021-03-24
ES2691475T3 (es) 2018-11-27
JP6706311B2 (ja) 2020-06-03
KR101964776B1 (ko) 2019-04-04
LT3424947T (lt) 2021-03-10
AU2018204700A1 (en) 2018-07-19
KR20140077219A (ko) 2014-06-23
JP2022093637A (ja) 2022-06-23
US20160021856A1 (en) 2016-01-28
PT2771357T (pt) 2018-11-09
CN114891798A (zh) 2022-08-12
IL232098A0 (en) 2014-05-28
CN107858333A (zh) 2018-03-30
CN107858333B (zh) 2022-05-27
IL305550B1 (en) 2024-10-01
KR102397961B1 (ko) 2022-05-13
CA2853707A1 (en) 2013-05-02
SMT201800553T1 (it) 2018-11-09
AU2018204700B2 (en) 2021-04-01
MX353134B (es) 2017-12-20
RS57893B1 (sr) 2019-01-31
IL315445A (en) 2024-11-01
US20210051930A1 (en) 2021-02-25
HK1198171A1 (en) 2015-03-13
SI3424947T1 (sl) 2021-04-30
BR112014009203B1 (pt) 2023-02-28
SI2771357T1 (sl) 2018-11-30
IL232098B (en) 2020-06-30
JP2024019646A (ja) 2024-02-09
IL274914B1 (en) 2023-10-01
CY1123831T1 (el) 2022-05-27
KR20200102001A (ko) 2020-08-28
IL274914B2 (en) 2024-02-01
SG10201914043XA (en) 2020-03-30
SG11201401030WA (en) 2014-04-28
JP2023024744A (ja) 2023-02-16
US20130109053A1 (en) 2013-05-02
AU2021203192B2 (en) 2024-04-11
AU2012327204B2 (en) 2016-01-21
HUE053444T2 (hu) 2021-06-28
MX379517B (es) 2025-03-10
HRP20210256T1 (hr) 2021-04-02
EP2771357A1 (en) 2014-09-03
JP2014532413A (ja) 2014-12-08
MX2014004894A (es) 2014-09-12
EP2771357B1 (en) 2018-07-18
EP3424947B1 (en) 2020-11-25
WO2013063361A1 (en) 2013-05-02
IL305550B2 (en) 2025-02-01
JP2020146045A (ja) 2020-09-17
AU2016202512A1 (en) 2016-05-12
RU2661106C2 (ru) 2018-07-11
JP2019033770A (ja) 2019-03-07
HRP20181626T1 (hr) 2018-12-14
CY1120945T1 (el) 2019-12-11
JP7305840B2 (ja) 2023-07-10
DK2771357T3 (en) 2018-10-29
EP3424947A1 (en) 2019-01-09
PL3424947T3 (pl) 2021-06-14
RU2014121160A (ru) 2015-12-10
IN2014CN03890A (enExample) 2015-10-16
PT3424947T (pt) 2021-03-01
CN107858332A (zh) 2018-03-30
PL2771357T3 (pl) 2018-12-31
LT2771357T (lt) 2018-10-25
DK3424947T3 (da) 2021-02-22
US20220386575A1 (en) 2022-12-08
CN104011071A (zh) 2014-08-27
CN114891798B (zh) 2025-12-02
AU2016202512C1 (en) 2018-10-11
KR102542272B1 (ko) 2023-06-13
KR20210133325A (ko) 2021-11-05
AU2018204700C1 (en) 2021-10-14
RS61455B1 (sr) 2021-03-31
JP6254528B2 (ja) 2017-12-27
US11528895B2 (en) 2022-12-20
NZ623147A (en) 2016-03-31
JP7656580B2 (ja) 2025-04-03
KR102321909B1 (ko) 2021-11-05

Similar Documents

Publication Publication Date Title
JP7656580B2 (ja) 遺伝子改変ｔ細胞受容体マウス
HK40049273A (en) Genetically modified t cell receptor mice
HK1198171B (en) Genetically modified t cell receptor mice

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6